research Kudos
The document cannot be understood or processed.
Search
for
Sort by
Research
870-900 / 1000+ results 
research Pioneer of the Month
The document's conclusion cannot be provided because the document is not readable or understandable.
research Finasteride-associated central retinal vein occlusion
research Live-cell Imaging and Analysis of Germline Stem Cell Mitosis in Caenorhabditis elegans
The protocol allows easy imaging of dividing cells in C. elegans and can be used for other organisms.
research Evolving eponymous signs in diagnostic dermoscopy
Dermoscopy is useful for diagnosing various skin conditions, and new patterns for diagnosis are emerging.
research Phytochemical profiling and evaluation of the anti-aging and anti-inflammatory potential of cultivated Eclipta alba (L.)
Eclipta alba has anti-aging and anti-inflammatory properties, making it a potential ingredient for cosmetics.
research "Eclipta alba (L.) Hassk., A Promising Medicinal Herb for Holistic Health: An overview "
False daisy is a medicinal herb with many health benefits, including hair growth promotion.
research Clobetasol/minoxidil
research Eclipta alba extract with potential for hair growth promoting activity
Eclipta alba extract may help hair grow similarly to Minoxidil.
research A case of encephalocraniocutaneous lipomatosis
The document reports a rare case of ECCL with a new association with optic disc colobomas.
research 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
research Lupus erythematosus. What’s new?
Lupus can progress to a more serious form, so careful monitoring is crucial.
research Phytochemical Analysis of Eclipta prostrata L. (L.) Leaves
Eclipta prostrata leaves contain various compounds with medicinal properties.
research LIGA R and D and prototyping[Lithography, Electroforming, and Assembly]
research Rome report
The document cannot be processed or understood.
research Report on the 6th Congress and Live Surgery Workshop of the ESHRS Berlin, GermanyFriday, May 30, 2003Saturday, May 31, 2003Sunday, June 1, 2003
The document's content could not be understood or processed.
research Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.
research Malignant Melanoma
The document's conclusion cannot be provided because the document is not readable or understandable.
research Alopecia Universalis With Remission During Pregnancy and Prednisolone Therapy
research Preovulatory oocyte transfer to a preovulatory follicle: An alternative to in vitro fertilization in the mare
research An Idea Whose Time Has Come
The document's conclusion cannot be summarized because the content is not accessible.
research 2000 Manfred Lucas and Follicle Awards
The document's conclusion cannot be summarized because the content is not accessible or understandable.
research IN VITRO HIV-1 REVERSE TRANSCRIPTASE INHIBITION BY ALKALOIDS ISOLATED FROM LEAVES OF ECLIPTA ALBA
Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.
research Demodex
Following a specific clinical sequence can help diagnose and treat Demodex mites in the eyes.
research The effect of melatonin treatment on hair follicle cycle in angora rabbits
research Scalp Hair Hypopigmentation in a Five-month-old Infant: A Quiz
research A brief lightening on medicinal activity and Pharmacological profile of plant Eclipta prostrata: A Review
Eclipta prostrata has many medicinal benefits, but more research is needed to understand how it works.
research Date.zip
I cannot summarize the document because it cannot be parsed.
research Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.
CDK4/6 inhibitors may cause hair loss in breast cancer patients.
research Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.